Journal article

Does IL28B genotyping still have a role in the era of direct-acting antiviral therapy for chronic hepatitis C infection?

JA Holmes, PV Desmond, AJ Thompson

Journal of Viral Hepatitis | WILEY | Published : 2012

DOI: 10.1111/jvh.12003

Citation metrics

33Web of Science
31Scopus

Keywords

Treatment Outcome
Science & Technology
Hepatitis C Virus
Il28b Polymoprhism
Drug Therapy, Combination
Antiviral Agents
Interleukin 28b
Ribavirin
Sustained Virological Response
Interferons
Hepatitis C, Chronic
Ns3 Protease
Life Sciences & Biomedicine
Ns5a Protein
Polymorphism, Genetic
Genetic-Variation
Prognosis
Cost-Effectiveness
Association
Interleukins
Virology
Spontaneous Clearance
Virus
Treatment Response
Telaprevir
Polymorphism
Gastroenterology & Hepatology
Infectious Diseases
Humans
Ns5b Polymerase
Genotype